Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients

(2010) Iwona K. Kolasa et al.   CANCER BIOLOGY & THERAPY

Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator

(2010) Seiko Ishida et al.   CANCER CELL

Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: Time for an evidence-based comparison

(2010) Maurie Markman   GYNECOLOGIC ONCOLOGY

Reactome: a database of reactions, pathways and biological processes

(2010) D. Croft et al.   NUCLEIC ACIDS RESEARCH

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer

(2009) Jianghong Li et al.   BMC CANCER

Novel strategies for reversing platinum resistance

(2009) Mian M.K. Shahzad et al.   DRUG RESISTANCE UPDATES

Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms

(2008) HuiJuan Wu et al.   CANCER LETTERS

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

(2008) C Garcia-Echeverria et al.   ONCOGENE